The consumption of reprocessed medical devices is expected to rise at an impressive CAGR of 14.9% from 2021 to 2028. In 2020, the global reprocessed medical devices market was worth US$ 2.05 billion, and the market is anticipated to surge to a valuation of US$ 5.9 billion by the end of 2028.
The consumption of reprocessed medical devices is expected to rise at an impressive CAGR of 14.9% from 2021 to 2028. In 2020, the global reprocessed medical devices market was worth US$ 2.05 billion, and the market is anticipated to surge to a valuation of US$ 5.9 billion by the end of 2028.
Increasing healthcare expenditure owing to the rising patient pool is expected to bolster demand for reprocessed medical devices as healthcare institutions focus on lowering operational costs. Increasing geriatric population, favorable regulatory policies, and rising focus on healthcare are anticipated to be other trends propelling the reprocessed medical devices market potential over the coming years.
Demand for reprocessed medical devices is anticipated to be high in developing economies where healthcare spending is less.
Key reprocessed medical device suppliers are focusing on launching new and innovative products to advance medical device reprocessing procedures and increase revenue potential.
In December 2021, PENTAX Medical announced the launch of PlasmaTYPHOON’s second generation systems, which is aimed at accelerating endoscope reprocessing and giving healthcare professionals more choices. These new systems will accelerate the process by reducing drying times from hours to minutes.
For more insights into the Market, Get A Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7251
Key Takeaways from the Market Study:
In 2020, the global reprocessed medical devices market held a revenue total of US$ 2.05 Bn.
Consumption of reprocessed medical devices is predicted to surge at an impressive CAGR of 14.9% from 2021 to 2028.
The reprocessed medical devices market is anticipated to be worth US$ 5.9 Bn by 2028.
Increasing focus on healthcare, rising healthcare expenditure, and growing popularity of reprocessed medical devices are anticipated to be prominent trends governing market potential.
The cardiovascular devices segment is anticipated to lead the global reprocessed medical devices sales over the coming years.
For Comprehensive Insights Ask An Analyst Here: https://www.factmr.com/connectus/sample?flag=AE&rep_id=7251
Winning Strategy:
Reprocessed medical device manufacturers are focusing on mergers and acquisitions to expand their product portfolios and increase their sales. Favorable regulatory policies are also expected to promote reprocessed medical device suppliers to advance their sales potential and increase revenue.
Reprocessed medical device companies are investing in the development of better reprocessing facilities to meet increasing demand. Favorable government initiatives to boost the adoption of reusable medical devices are also expected to be capitalized on by key reprocessed medical devices market players over the forecast period.
Key Segments Covered in Reprocessed Medical Devices Market Analysis
By Device Type
The reprocessed medical devices market is categorized into several key device types, including:
Cardiovascular Devices
Blood Pressure Cuffs / Tourniquet Cuffs
Cardiac Stabilization and Positioning Devices
Compression Sleeves (Deep Vein Thrombosis – DVT)
Diagnostic Electrophysiology Catheters
Electrophysiology Cables
General Surgery Devices
Balloon Inflation Devices
Infusion Pressure Bags
Laparoscopic Devices
Endoscopic Trocars & Components
Harmonic Scalpels
Orthopedic Devices
Orthopedic External Fixation Devices
Gastroenterology Devices
Biopsy Forceps
By Region
The report provides a comprehensive analysis of market trends and developments across key geographies:
North America
Latin America
Europe
East Asia
South Asia & Oceania
Middle East & Africa (MEA)
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=7251
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global reprocessed medical devices market, presenting historical demand data (2017-2020) and forecast statistics for the period of 2021-2028.
The study divulges essential insights on the market on the basis of device type (cardiovascular devices, general surgery devices, laparoscopic devices, orthopedic external fixation devices, gastroenterology biopsy forceps) and across six major regions (North America, Latin America, Europe, East Asia, South Asia & Oceania, and the Middle East & Africa).
Key Companies Profiled:
Stryker; Medline Industries Inc.; ReNu Medical; LUMITOS AG; Vanguard AG; Johnson & Johnson; Sterilmed Inc.; Hygia Health Services Inc.; Centurion Medical Products Corporation; Siemens Healthcare; Philips Healthcare; GE Healthcare; Suretech Medical Inc.
Industry News:
In February 2022, DePuy Synthes, the orthopedics company of Johnson & Johnson, announced the acquisition of CrossRoads Extremity Systems. This will bring CrossRoads’s EcoSMART instrument portfolio to DePuy Synthes and strengthen its reprocessing facilities.
Explore More Related Studies Published by Fact.MR Research:
The global ulcerative colitis therapeutics market is anticipated to rise at a CAGR of 5.1% from 2021 to 2027. In 2020, revenue from ulcerative colitis therapeutics was US$ 5.6 Bn, which is expected to reach US$ 7.9 Bn by 2027.
The global cystic fibrosis devices market is currently valued at US$ 825.09 million and is expected to increase at a massive CAGR of 10% from 2023 to 2033 and is projected to reach US$ 2.14 billion by 2033.
The global ostomy care market is anticipated to be valued at over US$ 3 Bn in 2021, likely to grow 1.6x through 2031 to reach US$ 5.3 Bn.
Global demand for fluid management systems is predicted to increase at a CAGR of 6% from 2023 to 2033. As a result, the global fluid management market is expected to increase from a value of US$ 15 billion in 2023 to US$ 27 billion by 2033-end.
The global gamma probe devices market is set to reach US$ 88.2 million in 2022 and expand at a high-value CAGR of 9.4% to end up at US$ 216.6 million by 2032.
